This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

2nd Annual JustStand Wellness Summit Tackles Global Workplace "Sitting Disease"* Epidemic

Stocks in this article: NTK

ST. PAUL, Minn., June 26, 2012 /PRNewswire/ -- Addressing the growing health crisis resulting from prolonged sitting and inactivity, Ergotron, a leading manufacturer of sit-to-stand office solutions and a subsidiary of Nortek, Inc. (Nasdaq "NTK"), is hosting the 2nd Annual JustStand™ Wellness Summit at St. Catherine University in St. Paul, Minnesota on Tuesday, July 10, 2012 from 8:30 a.m. to 4:15 p.m.

At the day-long event, researchers will be announcing breaking results from several studies which used the Ergotron WorkFit sit-stand workstations. Ergotron's WorkFit workstations, which enable postural rotation, give users the ability to easily alternate between a seated and standing position frequently during their day. Expert panels will also share perspectives, successes and challenges businesses face when creating corporate cultures that facilitate healthier, more active work routines.

The term "Sitting Disease" has been coined by the scientific community and is commonly used when referring to metabolic syndrome and the ill-effects of an overly sedentary lifestyle. The research lists physical inactivity and a sedentary lifestyle as key risk factors in 4 out of the top 7 killers in the U.S. In modern workplaces, more jobs require extended and prolonged sitting time, with an increasing percentage of this population spending more than seven hours sitting in an average day. The research also shows that employees that sit too much are open to not only the aches and pains of prolonged inactivity, but also back pain, metabolic syndrome, hypertension, diabetes, cardiovascular disease, and certain types of cancers.

"The concerns tied to prolonged sitting and inactivity impact every corner of the globe and it's time we all literally took a 'stand' to counter its impact," said Joel Hazzard, president and CEO, Ergotron. "The Summit presenters' research validates long-held assumptions that sit-to-stand computing can improve an employee's wellness and productivity while also positively impacting an employer's profitability."

The JustStand Wellness Summit will feature keynote presentations as well as interactive discussions. Business leaders will be sharing why they are leading the change with employee access to sit-stand solutions beyond the prescriptive bias. Confirmed presenters include:

  • Dr. David Dunstan: Head of the Physical Activity laboratory in the Division of Metabolism and Obesity at Baker IDI Heart and Diabetes Institute, Australia;
  • Dr. James Levine, MD, Ph.D. – Mayo Clinic: Ground-breaking obesity researcher; and world's leading expert in the field of N.E.A.T.™ (non-exercise activity thermogenesis) research; and
  • Dr. Nico Pronk Ph.D., FACSM: vice president for Health Management at HealthPartners; founding president of the International Association for Worksite Health Promotion (IAWHP).

The Summit is complimentary for anyone interested in learning about the risks of prolonged sitting and inactivity, however, registration is required due to limited space. For more information, or to view live streaming the day of the event, visit or follow the event on Twitter, hashtag #jsss12.

* "Sitting Disease" is a term the scientific community has coined to refer to metabolic syndrome and the ill-effects of an overly sedentary lifestyle.

SOURCE Ergotron, Inc.

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs